Skip to search formSkip to main contentSkip to account menu

complexin II

Known as: synaphin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Complexin II is reduced in Huntington's disease (HD) patients and in the R6/2 mouse model of HD. Mice lacking complexin II (Cplx2… 
2005
2005
Disturbance of synaptic transmission is currently viewed as an important pathophysiological mechanism and therapeutic target of… 
Highly Cited
2003
Highly Cited
2003
Exposure of pregnant women to stress during a critical period of fetal brain development is an environmental risk factor for… 
Highly Cited
2003
Highly Cited
2003
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat in the HD gene. We… 
Highly Cited
2002
Highly Cited
2002
Calcium-dependent synaptic vesicle exocytosis requires three SNARE (solubleN-ethylmaleimide-sensitive-factor attachment protein… 
Highly Cited
1999
Highly Cited
1999
The SNAP receptor (SNARE) complex is a core complex specialized for synaptic vesicle exocytosis, and the binding of SNAPs to the… 
Highly Cited
1995
Highly Cited
1995
We previously identified a 19 kDa protein associated with the docking/fusion complex involved in neurotransmitter release. A cDNA…